Chargement en cours...
Preoperative Serum IL-12p40 Is a Potential Predictor of Kasai Portoenterostomy Outcome in Infants with Biliary Atresia
The standard-of-care treatment for biliary atresia (BA) is surgical restoration of bile flow by Kasai portoenterostomy. We aimed to study serum interleukin- (IL-) 12p40, a natural antagonist for the proinflammatory IL-12p70, and its relation to surgical outcomes of BA. The study included 75 infants...
Enregistré dans:
| Publié dans: | Gastroenterol Res Pract |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Hindawi
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5447261/ https://ncbi.nlm.nih.gov/pubmed/28588613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/9089068 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|